Balasa Dinverno & Foltz’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.44M Buy
4,719
+385
+9% +$130K 0.09% 91
2022
Q2
$1.32M Buy
4,334
+325
+8% +$98K 0.08% 99
2022
Q1
$1.34M Sell
4,009
-14
-0.3% -$4.37K 0.09% 102
2021
Q4
$1.48M Sell
4,023
-36
-0.9% -$12.1K 0.1% 92
2021
Q3
$1.22M Buy
4,059
+336
+9% +$102K 0.08% 103
2021
Q2
$1.03M Sell
3,723
-123
-3% -$31.2K 0.07% 124
2021
Q1
$953K Sell
3,846
-14
-0.4% -$3.56K 0.08% 121
2020
Q4
$1M Sell
3,860
-78
-2% -$18K 0.08% 103
2020
Q3
$843K Buy
3,938
+1,551
+65% +$316K 0.08% 109
2020
Q2
$465K Buy
2,387
+221
+10% +$36.5K 0.05% 137
2020
Q1
$279K Buy
2,166
+111
+5% +$15.8K 0.04% 194
2019
Q4
$286K Buy
2,055
+325
+19% +$44.6K 0.03% 218
2019
Q3
$237K Buy
+1,730
New +$234K 0.03% 222

Other funds holding SNPS

Balasa Dinverno & Foltz's SNPS Position: Q3 2022 in Review

Balasa Dinverno & Foltz increased its Synopsys (SNPS) stake by 8.9% in Q3 2022, buying an estimated $130K and bringing the position to 4,719 shares worth $1.44M. The position accounts for 0.09% of the portfolio, ranked #91.

Balasa Dinverno & Foltz first reported a position in SNPS in Q3 2019 and has held it in 13 quarters since. The position peaked at $1.48M in Q4 2021. 879 funds tracked by Wall St. Rank hold SNPS as of Q3 2022.

  • Balasa Dinverno & Foltz held 4,719 shares of Synopsys worth $1.44M as of Q3 2022.
  • Balasa Dinverno & Foltz bought 385 Synopsys shares in Q3 2022, an estimated $130K.
  • Synopsys made up 0.09% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #91 holding.
  • Balasa Dinverno & Foltz first reported a position in Synopsys in Q3 2019 and has held it in 13 quarters since.
  • Balasa Dinverno & Foltz's Synopsys position peaked at $1.48M in Q4 2021.
  • 879 funds tracked by Wall St. Rank held Synopsys as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.